Cargando…
Antitumor Quinol PMX464 Is a Cytocidal Anti-trypanosomal Inhibitor Targeting Trypanothione Metabolism
Better drugs are urgently needed for the treatment of African sleeping sickness. We tested a series of promising anticancer agents belonging to the 4-substituted 4-hydroxycyclohexa-2,5-dienones class (“quinols”) and identified several with potent trypanocidal activity (EC(50) < 100 nm). In mammal...
Autores principales: | König, Janine, Wyllie, Susan, Wells, Geoffrey, Stevens, Malcolm F., Wyatt, Paul G., Fairlamb, Alan H. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
American Society for Biochemistry and Molecular Biology
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3048735/ https://www.ncbi.nlm.nih.gov/pubmed/21212280 http://dx.doi.org/10.1074/jbc.M110.214833 |
Ejemplares similares
-
PMX464, a thiol-reactive quinol and putative thioredoxin inhibitor, inhibits NF-κB-dependent proinflammatory activation of alveolar epithelial cells
por: Callister, M E, et al.
Publicado: (2008) -
Quinol derivatives as potential trypanocidal agents
por: Capes, Amy, et al.
Publicado: (2012) -
Methylglyoxal metabolism in trypanosomes and leishmania
por: Wyllie, Susan, et al.
Publicado: (2011) -
ATP-dependent ligases in trypanothione biosynthesis – kinetics of catalysis and inhibition by phosphinic acid pseudopeptides
por: Oza, Sandra L, et al.
Publicado: (2008) -
Chemical Validation of Trypanothione Synthetase: A POTENTIAL DRUG TARGET FOR HUMAN TRYPANOSOMIASIS
por: Torrie, Leah S., et al.
Publicado: (2009)